Lmr Partners LLP Ionis Pharmaceuticals Inc Transaction History

Lmr Partners LLP

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 15, 2020	SELL	$41.6 - $63.4 $1.2 Million - $1.83 Million	-28,809 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$53.85 - $65.27 $1.33 Million - $1.62 Million	24,781 Added 615.22%	28,809 $1.74 Million
Q3 2019 Nov 14, 2019	BUY	$59.06 - $72.15 $237,893 - $290,620	4,028 New	4,028 $241,000
Q2 2019 Aug 14, 2019	SELL	$62.09 - $86.14 $3.23 Million - $4.47 Million	-51,950 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$52.92 - $81.17 $2.75 Million - $4.22 Million	51,950 New	51,950 $4.22 Million

402

136M

862K

582K

Ticker IONS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 141,940,992
Market Cap $5.19B
Description
Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...

Get notified when there are updates to the investment portfolio of Lmr Partners LLP, based on Form 13F filings with the SEC.

Stay updated on Lmr Partners LLP with notifications on news.